miércoles, 9 de septiembre de 2015

Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.

Abstract

BACKGROUND:
Stereotactic body radiation therapy (SBRT) has demonstrated high rates of local control with low morbidity and has now emerged as the standard of care for medically inoperable, early stage non-small cell lung cancer (NSCLC). However, the impact of lung SBRT on survival in the elderly population is less clear given competing comorbid conditions. An analysis of the National Cancer Data Base (NCDB) was undertaken to determine whether definitive SBRT improves survival relative to observation alone patients ages 70 years and older.

METHODS:
The NCDB, a retrospective national database that captures approximately 70% of all patients treated for cancer, was queried for patients aged 70 years or older with early stage (T1-T3N0M0) NSCLC from 2003 to 2006. Overall survival was compared between patients who received stereotactic body radiotherapy alone and those who received no treatment. An extended Cox proportional hazards model was applied to estimate the treatment effect of SBRT.

RESULTS:
In total, 3147 patients met the selection criteria for this analysis. SBRT was elivered to 258 patients (8.2%), and 2889 patients (91.8%) received no treatment. There was no significant difference in the distribution of Charlson/Deyo comorbidity index scores between the 2 groups (P = .076). Multivariable analysis revealed improved overall survival with SBRT compared with observation for the entire cohort (hazard ratio, 0.64; P < .001).

CONCLUSIONS:
SBRT is associated with improved survival in elderly patients with early stage NSCLC who have concurrent comorbid conditions compared with observation alone. The current data support the use of SBRT for the treatment of elderly patients with early stage NSCLC who have limiting comorbid conditions.
Source:  2015 Sep 8. doi: 10.1002/cncr.29640. 

1 comentario:

  1. Thank you for sharing, I was fighting my cancer. A week after I turned 45 I was diagnosed with stage 4 colon cancer that spread to my liver. It was a long hard journey but July 19 will be 5 years cancer free after drinking Dr Itua herbal medicine. I wish the best for anyone with cancer and I will recommend Dr Itua to anyone with cancer and Dr Itua will cure you completely. I’m thankful I meant Dr Itua Stay on them about the ox platinum that can leave you with permanent damage. They backed down on mine after drinking dr itua herbal medicine and I don’t have any permanent side effects. Much love from California stays strong . If you have any questions You can write to Dr Itua Herbal Center on drituaherbalcenter@gmail.com.

    ResponderEliminar